GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: BRII-693 | F365 | QPX9003
Compound class:
Peptide
Comment: Soralimixin is a lipopeptide with activity against Gram-negative bacteria. It is a polymyxin analogue, rationally designed to overcome the clinical limitations of this class of antibacterial compounds [1].
Structure match for the INN soralimixin is included in WHO proposed list 134 (Feb 2026). |
|
|||||||||||||||||
Classification ![]() |
|
| Compound class | Peptide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13962 | soralimixin |
Synonyms ![]() |
| BRII-693 | F365 | QPX9003 |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Soralimixin |
| Other databases | |
| CAS Registry No. | 1814918-91-6 (source: WHO INN record) |
| GtoPdb PubChem SID | 523352164 |
| PubChem CID | 176507621 |
| Search Google for chemical match using the InChIKey | XRXBRIQKVLXFMJ-BCLXPCSMSA-N |
| Search Google for chemicals with the same backbone | XRXBRIQKVLXFMJ |
| Search PubMed clinical trials | soralimixin |
| Search PubMed titles | soralimixin |
| Search PubMed titles/abstracts | soralimixin |
| UniChem Compound Search for chemical match using the InChIKey | XRXBRIQKVLXFMJ-BCLXPCSMSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | XRXBRIQKVLXFMJ-BCLXPCSMSA-N |